| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 5.13e-06 | 118 | 214 | 9 | GO:0003774 | |
| GeneOntologyMolecularFunction | calcium ion binding | CAPN12 SWAP70 CETN3 ENPP3 PCDH17 DUOX1 MAN1A2 HMCN2 EEF2K NOTCH1 CACNA1B CACNA1E EFCAB6 DLL4 LDLR TGM2 CADPS CCBE1 PLCH2 PITPNM3 SDF4 EML1 PLCH1 | 6.03e-06 | 749 | 214 | 23 | GO:0005509 |
| GeneOntologyMolecularFunction | high voltage-gated calcium channel activity | 1.18e-05 | 14 | 214 | 4 | GO:0008331 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity involved in regulation of cytosolic calcium levels | 9.72e-05 | 9 | 214 | 3 | GO:0099511 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity involved in regulation of presynaptic cytosolic calcium levels | 9.72e-05 | 9 | 214 | 3 | GO:0099626 | |
| GeneOntologyMolecularFunction | inward rectifier potassium channel activity | 2.15e-04 | 28 | 214 | 4 | GO:0005242 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic cation channel activity | 2.39e-04 | 152 | 214 | 8 | GO:0022843 | |
| GeneOntologyMolecularFunction | alpha-actinin binding | 3.22e-04 | 31 | 214 | 4 | GO:0051393 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity | 7.94e-04 | 182 | 214 | 8 | GO:0005244 | |
| GeneOntologyMolecularFunction | hydrolase activity, hydrolyzing O-glycosyl compounds | 8.52e-04 | 103 | 214 | 6 | GO:0004553 | |
| GeneOntologyMolecularFunction | voltage-gated channel activity | 8.52e-04 | 184 | 214 | 8 | GO:0022832 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 8.79e-04 | 18 | 214 | 3 | GO:0008569 | |
| GeneOntologyMolecularFunction | microtubule motor activity | 9.28e-04 | 70 | 214 | 5 | GO:0003777 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity involved in cardiac muscle cell action potential | 1.12e-03 | 5 | 214 | 2 | GO:0086007 | |
| GeneOntologyMolecularFunction | DNA demethylase activity | 1.12e-03 | 5 | 214 | 2 | GO:0035514 | |
| GeneOntologyMolecularFunction | broad specificity oxidative DNA demethylase activity | 1.12e-03 | 5 | 214 | 2 | GO:0035516 | |
| GeneOntologyMolecularFunction | actinin binding | 1.14e-03 | 43 | 214 | 4 | GO:0042805 | |
| GeneOntologyBiologicalProcess | lipid storage | 1.39e-05 | 105 | 214 | 8 | GO:0019915 | |
| GeneOntologyBiologicalProcess | maintenance of location | ASXL1 PSEN1 VPS13C SREBF1 ZFYVE1 FTO CACNA1C ZC3H12A ANK2 CAV1 ABCG1 PLCH2 TREM2 PRKCE PLCH1 | 1.78e-05 | 396 | 214 | 15 | GO:0051235 |
| GeneOntologyBiologicalProcess | inorganic cation import across plasma membrane | KCNJ3 KCNJ4 KCNJ12 CACNA1B CACNA1C CACNA1D CACNA1E CAV1 KCNJ18 | 1.79e-05 | 142 | 214 | 9 | GO:0098659 |
| GeneOntologyBiologicalProcess | inorganic ion import across plasma membrane | KCNJ3 KCNJ4 KCNJ12 CACNA1B CACNA1C CACNA1D CACNA1E CAV1 KCNJ18 | 1.79e-05 | 142 | 214 | 9 | GO:0099587 |
| GeneOntologyBiologicalProcess | positive regulation of membrane depolarization | 1.86e-05 | 16 | 214 | 4 | GO:1904181 | |
| GeneOntologyBiologicalProcess | actin filament-based movement | 3.23e-05 | 153 | 214 | 9 | GO:0030048 | |
| GeneOntologyBiologicalProcess | membrane depolarization | 3.88e-05 | 121 | 214 | 8 | GO:0051899 | |
| GeneOntologyBiologicalProcess | regulation of membrane depolarization | 4.01e-05 | 61 | 214 | 6 | GO:0003254 | |
| GeneOntologyBiologicalProcess | regulation of lipid storage | 4.01e-05 | 61 | 214 | 6 | GO:0010883 | |
| GeneOntologyBiologicalProcess | amyloid-beta clearance by cellular catabolic process | 5.94e-05 | 8 | 214 | 3 | GO:0150094 | |
| GeneOntologyBiologicalProcess | regulation of heart contraction | ADCY10 SREBF1 KCNJ3 KCNJ12 CACNA1B CACNA1C CACNA1D CACNA1E ZC3H12A ANK2 CAV1 | 6.15e-05 | 249 | 214 | 11 | GO:0008016 |
| GeneOntologyBiologicalProcess | regulation of heart rate by cardiac conduction | 6.34e-05 | 41 | 214 | 5 | GO:0086091 | |
| GeneOntologyBiologicalProcess | cilium assembly | IFT43 MKS1 SGSM3 DNAH5 DNAH8 NOTCH1 HDAC6 DYNC2I2 CCDC39 TBC1D17 DNAH1 NPHP3 TXNDC15 HYDIN PCNT | 6.60e-05 | 444 | 214 | 15 | GO:0060271 |
| GeneOntologyBiologicalProcess | cardiac atrium development | 7.14e-05 | 42 | 214 | 5 | GO:0003230 | |
| GeneOntologyBiologicalProcess | positive regulation of establishment of protein localization | ADCY10 MYH10 PSEN1 FZD5 FTO CACNA1C CACNA1D ZC3H12A WRAP53 ABCG1 TREM2 PRKCE HYAL2 PCNT | 8.62e-05 | 403 | 214 | 14 | GO:1904951 |
| GeneOntologyBiologicalProcess | pericardium morphogenesis | 8.83e-05 | 9 | 214 | 3 | GO:0003344 | |
| GeneOntologyBiologicalProcess | regulation of autophagy of mitochondrion | 1.00e-04 | 45 | 214 | 5 | GO:1903146 | |
| GeneOntologyBiologicalProcess | positive regulation of engulfment of apoptotic cell | 1.07e-04 | 2 | 214 | 2 | GO:1901076 | |
| GeneOntologyBiologicalProcess | regulation of apoptotic cell clearance | 1.25e-04 | 10 | 214 | 3 | GO:2000425 | |
| GeneOntologyBiologicalProcess | calcium ion import across plasma membrane | 1.37e-04 | 48 | 214 | 5 | GO:0098703 | |
| GeneOntologyBiologicalProcess | calcium ion import into cytosol | 1.37e-04 | 48 | 214 | 5 | GO:1902656 | |
| GeneOntologyBiologicalProcess | cilium organization | IFT43 MKS1 SGSM3 DNAH5 DNAH8 NOTCH1 HDAC6 DYNC2I2 CCDC39 TBC1D17 DNAH1 NPHP3 TXNDC15 HYDIN PCNT | 1.42e-04 | 476 | 214 | 15 | GO:0044782 |
| GeneOntologyBiologicalProcess | import across plasma membrane | PSEN1 KCNJ3 KCNJ4 KCNJ12 CACNA1B CACNA1C CACNA1D CACNA1E CAV1 KCNJ18 | 1.51e-04 | 230 | 214 | 10 | GO:0098739 |
| GeneOntologyBiologicalProcess | positive regulation of cholesterol efflux | 1.64e-04 | 27 | 214 | 4 | GO:0010875 | |
| GeneOntologyBiologicalProcess | ER-nucleus signaling pathway | 2.20e-04 | 53 | 214 | 5 | GO:0006984 | |
| GeneOntologyBiologicalProcess | membrane repolarization | 2.85e-04 | 56 | 214 | 5 | GO:0086009 | |
| GeneOntologyBiologicalProcess | heart contraction | ADCY10 SREBF1 KCNJ3 KCNJ12 CACNA1B CACNA1C CACNA1D CACNA1E ZC3H12A ANK2 CAV1 | 2.97e-04 | 298 | 214 | 11 | GO:0060047 |
| GeneOntologyBiologicalProcess | regulation of engulfment of apoptotic cell | 3.19e-04 | 3 | 214 | 2 | GO:1901074 | |
| GeneOntologyBiologicalProcess | epithelial cilium movement involved in extracellular fluid movement | 3.64e-04 | 59 | 214 | 5 | GO:0003351 | |
| GeneOntologyBiologicalProcess | cell communication involved in cardiac conduction | 3.64e-04 | 59 | 214 | 5 | GO:0086065 | |
| GeneOntologyBiologicalProcess | regulation of heart rate | 4.02e-04 | 129 | 214 | 7 | GO:0002027 | |
| GeneOntologyBiologicalProcess | heart process | ADCY10 SREBF1 KCNJ3 KCNJ12 CACNA1B CACNA1C CACNA1D CACNA1E ZC3H12A ANK2 CAV1 | 4.03e-04 | 309 | 214 | 11 | GO:0003015 |
| GeneOntologyBiologicalProcess | cell-cell signaling involved in cardiac conduction | 4.09e-04 | 34 | 214 | 4 | GO:0086019 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell contraction | 4.19e-04 | 93 | 214 | 6 | GO:0086003 | |
| GeneOntologyBiologicalProcess | calcium ion transmembrane import into cytosol | 4.56e-04 | 217 | 214 | 9 | GO:0097553 | |
| GeneOntologyBiologicalProcess | positive regulation of cholesterol biosynthetic process | 4.57e-04 | 15 | 214 | 3 | GO:0045542 | |
| GeneOntologyBiologicalProcess | positive regulation of sterol biosynthetic process | 4.57e-04 | 15 | 214 | 3 | GO:0106120 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell action potential involved in contraction | 4.59e-04 | 62 | 214 | 5 | GO:0086002 | |
| GeneOntologyBiologicalProcess | extracellular transport | 4.59e-04 | 62 | 214 | 5 | GO:0006858 | |
| GeneOntologyBiologicalProcess | positive regulation of protein localization | ADCY10 MYH10 PSEN1 ABCA7 PARP1 FZD5 FTO CACNA1C CACNA1D ZC3H12A WRAP53 ABCG1 TREM2 PRKCE HYAL2 PCNT | 4.70e-04 | 591 | 214 | 16 | GO:1903829 |
| GeneOntologyCellularComponent | T-tubule | 1.61e-05 | 79 | 213 | 7 | GO:0030315 | |
| GeneOntologyCellularComponent | dynein complex | 1.79e-05 | 54 | 213 | 6 | GO:0030286 | |
| GeneOntologyCellularComponent | microtubule associated complex | 4.19e-05 | 161 | 213 | 9 | GO:0005875 | |
| GeneOntologyCellularComponent | axonemal dynein complex | 1.12e-04 | 25 | 213 | 4 | GO:0005858 | |
| GeneOntologyCellularComponent | sarcolemma | 1.50e-04 | 190 | 213 | 9 | GO:0042383 | |
| GeneOntologyCellularComponent | myosin II filament | 3.08e-04 | 3 | 213 | 2 | GO:0097513 | |
| GeneOntologyCellularComponent | caveolar macromolecular signaling complex | 3.08e-04 | 3 | 213 | 2 | GO:0002095 | |
| Domain | Ca_chan_IQ | 5.71e-07 | 7 | 214 | 4 | SM01062 | |
| Domain | Ca_chan_IQ | 5.71e-07 | 7 | 214 | 4 | PF08763 | |
| Domain | VDCC_a1su_IQ | 5.71e-07 | 7 | 214 | 4 | IPR014873 | |
| Domain | GPHH | 5.71e-07 | 7 | 214 | 4 | PF16905 | |
| Domain | GPHH_dom | 5.71e-07 | 7 | 214 | 4 | IPR031649 | |
| Domain | VDCCAlpha1 | 3.33e-06 | 10 | 214 | 4 | IPR002077 | |
| Domain | ATPase_dyneun-rel_AAA | 1.53e-05 | 14 | 214 | 4 | IPR011704 | |
| Domain | AAA_5 | 1.53e-05 | 14 | 214 | 4 | PF07728 | |
| Domain | IRK | 2.74e-05 | 16 | 214 | 4 | PF01007 | |
| Domain | K_chnl_inward-rec_Kir_cyto | 2.74e-05 | 16 | 214 | 4 | IPR013518 | |
| Domain | - | 2.74e-05 | 16 | 214 | 4 | 2.60.40.1400 | |
| Domain | K_chnl_inward-rec_Kir | 2.74e-05 | 16 | 214 | 4 | IPR016449 | |
| Domain | HELP | 2.89e-05 | 6 | 214 | 3 | PF03451 | |
| Domain | HELP | 2.89e-05 | 6 | 214 | 3 | IPR005108 | |
| Domain | K_chnl_inward-rec_Kir2.2 | 1.31e-04 | 2 | 214 | 2 | IPR003272 | |
| Domain | Transform_prot_C-ets | 1.31e-04 | 2 | 214 | 2 | IPR016311 | |
| Domain | Ig_E-set | 1.95e-04 | 104 | 214 | 7 | IPR014756 | |
| Domain | EF_hand_dom | CAPN12 SWAP70 CETN3 DUOX1 CACNA1B CACNA1E EFCAB6 PLCH2 SDF4 PLCH1 | 3.56e-04 | 232 | 214 | 10 | IPR002048 |
| Domain | K_chnl_inward-rec_Kir_N | 3.89e-04 | 3 | 214 | 2 | IPR013673 | |
| Domain | CAC1F_C | 3.89e-04 | 3 | 214 | 2 | IPR031688 | |
| Domain | IRK_N | 3.89e-04 | 3 | 214 | 2 | PF08466 | |
| Domain | - | 3.89e-04 | 3 | 214 | 2 | 4.10.1130.10 | |
| Domain | CAC1F_C | 3.89e-04 | 3 | 214 | 2 | PF16885 | |
| Domain | Dynein_heavy_chain_D4_dom | 4.92e-04 | 14 | 214 | 3 | IPR024317 | |
| Domain | Dynein_HC_stalk | 4.92e-04 | 14 | 214 | 3 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 4.92e-04 | 14 | 214 | 3 | IPR013602 | |
| Domain | DHC_N2 | 4.92e-04 | 14 | 214 | 3 | PF08393 | |
| Domain | MT | 4.92e-04 | 14 | 214 | 3 | PF12777 | |
| Domain | AAA_8 | 4.92e-04 | 14 | 214 | 3 | PF12780 | |
| Domain | EF-hand-dom_pair | CAPN12 SWAP70 CETN3 DUOX1 CACNA1B CACNA1C EFCAB6 PHF24 PLCH2 SDF4 PLCH1 | 4.94e-04 | 287 | 214 | 11 | IPR011992 |
| Domain | DHC_fam | 6.10e-04 | 15 | 214 | 3 | IPR026983 | |
| Domain | Dynein_heavy | 6.10e-04 | 15 | 214 | 3 | PF03028 | |
| Domain | Dynein_heavy_dom | 6.10e-04 | 15 | 214 | 3 | IPR004273 | |
| Domain | RetinoicA-induced_16-like | 7.72e-04 | 4 | 214 | 2 | IPR019384 | |
| Domain | RAI16-like | 7.72e-04 | 4 | 214 | 2 | PF10257 | |
| Domain | VDCC_L_a1su | 7.72e-04 | 4 | 214 | 2 | IPR005446 | |
| Domain | Gal_mutarotase_SF_dom | 8.96e-04 | 17 | 214 | 3 | IPR011013 | |
| Domain | Myosin_head_motor_dom | 9.12e-04 | 38 | 214 | 4 | IPR001609 | |
| Domain | MYOSIN_MOTOR | 9.12e-04 | 38 | 214 | 4 | PS51456 | |
| Domain | Myosin_head | 9.12e-04 | 38 | 214 | 4 | PF00063 | |
| Domain | MYSc | 9.12e-04 | 38 | 214 | 4 | SM00242 | |
| Domain | WD40 | DCAF8 EML5 DYNC1I1 DYNC2I2 EML4 NUP214 WRAP53 SCAP ELP2 EML1 | 1.08e-03 | 268 | 214 | 10 | SM00320 |
| Domain | WD40_repeat | DCAF8 EML5 DYNC1I1 DYNC2I2 EML4 NUP214 WRAP53 SCAP ELP2 EML1 | 1.21e-03 | 272 | 214 | 10 | IPR001680 |
| Domain | Myosin-like_IQ_dom | 1.26e-03 | 19 | 214 | 3 | IPR027401 | |
| Domain | - | 1.26e-03 | 19 | 214 | 3 | 4.10.270.10 | |
| Domain | GLYCOSYL_HYDROL_F31_2 | 1.28e-03 | 5 | 214 | 2 | PS00707 | |
| Domain | - | 1.33e-03 | 42 | 214 | 4 | 3.20.20.70 | |
| Domain | EF_HAND_2 | 1.42e-03 | 231 | 214 | 9 | PS50222 | |
| Domain | Aldolase_TIM | 1.59e-03 | 44 | 214 | 4 | IPR013785 | |
| Pathway | KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_VGCC_CA2_APOPTOTIC_PATHWAY | 2.96e-05 | 6 | 163 | 3 | M47762 | |
| Pathway | BIOCARTA_S1P_PATHWAY | 2.96e-05 | 6 | 163 | 3 | MM1556 | |
| Pathway | BIOCARTA_ERAD_PATHWAY | 5.83e-05 | 19 | 163 | 4 | M22013 | |
| Pathway | BIOCARTA_S1P_PATHWAY | 8.14e-05 | 8 | 163 | 3 | M22036 | |
| Pathway | KEGG_MEDICUS_REFERENCE_VGCC_CA2_APOPTOTIC_PATHWAY | 1.29e-04 | 23 | 163 | 4 | M47666 | |
| Pathway | KEGG_DORSO_VENTRAL_AXIS_FORMATION | 1.53e-04 | 24 | 163 | 4 | M11190 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_ENTRY_VOLTAGE_GATED_CA2_CHANNEL | 1.80e-04 | 25 | 163 | 4 | M47948 | |
| Pathway | KEGG_TYPE_II_DIABETES_MELLITUS | 2.01e-04 | 47 | 163 | 5 | M19708 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_CAM_VGCC_RYR_SIGNALING_PATHWAY | 2.34e-04 | 11 | 163 | 3 | M47958 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | VWA5B2 ALKBH4 SIPA1L3 INTS1 SREBF1 FHIP1B ABCA7 MYORG DUS1L FASN MDN1 NCAPD2 NOTCH1 SMG6 FRAS1 NUP214 STK32C WRAP53 ADGRA2 LDLR TBC1D17 SCAP DNAJC14 ZNF335 PCNX1 SDF4 ESPL1 PCNT | 4.12e-10 | 1105 | 218 | 28 | 35748872 |
| Pubmed | PCYT1A ZNF234 DCAF8 SIPA1L3 ETS2 CMAS GTF3C4 PARP1 NAA25 MAN1A2 NMT2 SGSM3 DYNC1I1 CEP85 HDAC6 ANK2 WRAP53 KRIT1 ATF6 TXNDC15 FBH1 DNAJC14 MYH14 CADPS LGI3 COPS4 DNAI7 PCNT SOS1 | 2.72e-09 | 1285 | 218 | 29 | 35914814 | |
| Pubmed | 7.47e-09 | 5 | 218 | 4 | 11296258 | ||
| Pubmed | 7.47e-09 | 5 | 218 | 4 | 15451373 | ||
| Pubmed | 2.43e-07 | 3 | 218 | 3 | 8083233 | ||
| Pubmed | Microcephalin and pericentrin regulate mitotic entry via centrosome-associated Chk1. | 2.43e-07 | 3 | 218 | 3 | 19546241 | |
| Pubmed | ASXL1 MYH10 FHIP1B CSMD3 RNF157 TRIL LRFN2 GANAB FRAS1 PHF24 NUP214 CADPS SENP7 PCNT | 3.42e-07 | 407 | 218 | 14 | 12693553 | |
| Pubmed | CTU2 MYH10 PARP1 GANAB TXNL4A MOGS SUPT6H NMT2 FRAS1 WRAP53 STT3B USO1 CHTF18 COPS4 ELP2 CCDC9 RPAP2 | 9.33e-07 | 653 | 218 | 17 | 33742100 | |
| Pubmed | 9.67e-07 | 4 | 218 | 3 | 20798526 | ||
| Pubmed | 1.62e-06 | 32 | 218 | 5 | 20301301 | ||
| Pubmed | 1.94e-06 | 15 | 218 | 4 | 20188150 | ||
| Pubmed | 1.94e-06 | 15 | 218 | 4 | 24453333 | ||
| Pubmed | 2.41e-06 | 5 | 218 | 3 | 16177047 | ||
| Pubmed | MAGI1 as a link between endothelial activation and ER stress drives atherosclerosis. | 2.41e-06 | 5 | 218 | 3 | 30944250 | |
| Pubmed | DCAF8 BMS1 CMAS PARP1 GANAB MDN1 MOGS SUPT6H EEF2K FRAS1 CAD ANK2 PKP4 CAV1 TBC1D17 ESF1 STT3B ATF6 DNAJC14 COPS4 SDF4 ELP2 CTNND1 PLCH1 ESPL1 PCNT | 2.53e-06 | 1487 | 218 | 26 | 33957083 | |
| Pubmed | TPP2 MYH10 PSEN1 CETN3 SIPA1L3 CMAS GTF3C4 PARP1 MDN1 MYO19 PKP4 TGM2 COPS4 SDF4 CTNND1 RPAP2 | 2.93e-06 | 634 | 218 | 16 | 34591612 | |
| Pubmed | 3.35e-06 | 17 | 218 | 4 | 2355006 | ||
| Pubmed | MYH10 AZGP1 INTS1 SREBF1 INO80D CDC45 PARP1 RBSN FASN GANAB MOGS CAD CEP85 DLL4 NUP214 LDLR PREX2 ESF1 STT3B SCAP DNAJC14 MTMR9 PCNT SOS1 | 3.59e-06 | 1327 | 218 | 24 | 32694731 | |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | MYH10 GTF3C4 PARP1 DUOX1 FASN GANAB MDN1 PDLIM3 MOGS ELAPOR1 CAD DNAH1 TGM2 MYH14 PCNX1 EML1 CCDC9 HYDIN | 3.91e-06 | 807 | 218 | 18 | 30575818 |
| Pubmed | Voltage-gated calcium channels in developing GnRH-1 neuronal system in the mouse. | 4.79e-06 | 6 | 218 | 3 | 16029198 | |
| Pubmed | 4.79e-06 | 6 | 218 | 3 | 7580148 | ||
| Pubmed | 6.72e-06 | 20 | 218 | 4 | 12560567 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | MAGI1 CPAMD8 MYH10 DCAF8 VPS13C SIPA1L3 ZP3 LRFN2 SUPT6H KCNJ3 RASSF3 SMG6 CACNA1C MCPH1 LAMA3 STK32C DNAH1 ATF6 ABCG1 MYH14 PRKCE CTNND1 PCNT RPAP2 KLHL26 | 8.05e-06 | 1489 | 218 | 25 | 28611215 |
| Pubmed | 8.35e-06 | 7 | 218 | 3 | 9256245 | ||
| Pubmed | 8.35e-06 | 7 | 218 | 3 | 12900400 | ||
| Pubmed | Differential expression and function of ABCG1 and ABCG4 during development and aging. | 1.01e-05 | 22 | 218 | 4 | 19633360 | |
| Pubmed | 1.01e-05 | 22 | 218 | 4 | 8673525 | ||
| Pubmed | 1.01e-05 | 22 | 218 | 4 | 11530211 | ||
| Pubmed | Effect of various glycosidase treatments on the resistance of the HIV-1 envelope to degradation. | 1.01e-05 | 22 | 218 | 4 | 9109416 | |
| Pubmed | TPP2 MYH10 SIPA1L3 BMS1 NUDT12 PARP1 PTPN3 GANAB FTO NOTCH1 KIF22 CAD CEP85 PKP4 ESF1 SDF4 ELP2 CTNND1 MTMR9 PCNT | 1.14e-05 | 1049 | 218 | 20 | 27880917 | |
| Pubmed | 1.21e-05 | 23 | 218 | 4 | 8093218 | ||
| Pubmed | 1.21e-05 | 23 | 218 | 4 | 1736542 | ||
| Pubmed | Glycosylation inhibitors block the expression of LAV/HTLV-III (HIV) glycoproteins. | 1.21e-05 | 23 | 218 | 4 | 3099781 | |
| Pubmed | Role of protein N-glycosylation in pathogenesis of human immunodeficiency virus type 1. | 1.21e-05 | 23 | 218 | 4 | 3264072 | |
| Pubmed | 1.33e-05 | 8 | 218 | 3 | 28330839 | ||
| Pubmed | Cilia gene mutations cause atrioventricular septal defects by multiple mechanisms. | 1.71e-05 | 25 | 218 | 4 | 27340223 | |
| Pubmed | Effect of N-(3-phenyl-2-propenyl)-1-deoxynojirimycin on the lectin binding to HIV-1 glycoproteins. | 1.71e-05 | 25 | 218 | 4 | 2283726 | |
| Pubmed | 1.98e-05 | 9 | 218 | 3 | 16382099 | ||
| Pubmed | 2.01e-05 | 26 | 218 | 4 | 8218172 | ||
| Pubmed | 2.35e-05 | 27 | 218 | 4 | 24550280 | ||
| Pubmed | TPP2 PCYT1A CTU2 MYH10 SWAP70 CD109 BMS1 PARP1 FASN GANAB MOGS KIF22 CAD NUP214 CAV1 LDLR STT3B ATF6 TXNDC15 BAZ1A COPS4 SDF4 | 2.49e-05 | 1297 | 218 | 22 | 33545068 | |
| Pubmed | 2.82e-05 | 10 | 218 | 3 | 14960569 | ||
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | MYH10 VPS13C AZGP1 BMS1 CDC45 PARP1 FASN GANAB MDN1 MOGS SUPT6H NCAPD2 MYO18B DNAH5 CAD NUP214 ESF1 STT3B USO1 MYH14 BAZ1A COPS4 CTNND1 | 3.50e-05 | 1425 | 218 | 23 | 30948266 |
| Pubmed | A stronger DNA damage-induced G2 checkpoint due to over-activated CHK1 in the absence of PARP-1. | 3.91e-05 | 2 | 218 | 2 | 17102615 | |
| Pubmed | 3.91e-05 | 2 | 218 | 2 | 7963676 | ||
| Pubmed | 3.91e-05 | 2 | 218 | 2 | 12028586 | ||
| Pubmed | 3.91e-05 | 2 | 218 | 2 | 24726443 | ||
| Pubmed | NOTCH1 and DLL4 are involved in the human tuberculosis progression and immune response activation. | 3.91e-05 | 2 | 218 | 2 | 32801053 | |
| Pubmed | 3.91e-05 | 2 | 218 | 2 | 25455140 | ||
| Pubmed | 3.91e-05 | 2 | 218 | 2 | 17246260 | ||
| Pubmed | Implications of Dll4-Notch signaling activation in primary glioblastoma multiforme. | 3.91e-05 | 2 | 218 | 2 | 23787764 | |
| Pubmed | 3.91e-05 | 2 | 218 | 2 | 17246029 | ||
| Pubmed | 3.91e-05 | 2 | 218 | 2 | 17246039 | ||
| Pubmed | 3.91e-05 | 2 | 218 | 2 | 17246054 | ||
| Pubmed | ETS-1 and ETS-2 are upregulated in a transgenic mouse model of pigmented ocular neoplasm. | 3.91e-05 | 2 | 218 | 2 | 18958307 | |
| Pubmed | Genetic basis of susceptibility to splenic lipofuscinosis in mice. | 3.91e-05 | 2 | 218 | 2 | 7117836 | |
| Pubmed | Caveolin-1 interacts with a lipid raft-associated population of fatty acid synthase. | 3.91e-05 | 2 | 218 | 2 | 18635971 | |
| Pubmed | Enhanced ABCG1 expression increases atherosclerosis in LDLr-KO mice on a western diet. | 3.91e-05 | 2 | 218 | 2 | 17070501 | |
| Pubmed | 3.91e-05 | 2 | 218 | 2 | 24386421 | ||
| Pubmed | 3.91e-05 | 2 | 218 | 2 | 18802406 | ||
| Pubmed | Evidence for a physical interaction between presenilin and Notch. | 3.91e-05 | 2 | 218 | 2 | 10077672 | |
| Pubmed | 3.91e-05 | 2 | 218 | 2 | 20193271 | ||
| Pubmed | 3.91e-05 | 2 | 218 | 2 | 10942432 | ||
| Pubmed | Ca1.2 and CaV1.3 neuronal L-type calcium channels: differential targeting and signaling to pCREB. | 3.91e-05 | 2 | 218 | 2 | 16706838 | |
| Pubmed | 3.91e-05 | 2 | 218 | 2 | 23761887 | ||
| Pubmed | 3.91e-05 | 2 | 218 | 2 | 14981074 | ||
| Pubmed | 3.91e-05 | 2 | 218 | 2 | 17141191 | ||
| Pubmed | 3.91e-05 | 2 | 218 | 2 | 12606379 | ||
| Pubmed | 3.91e-05 | 2 | 218 | 2 | 26435347 | ||
| Pubmed | Blocking Notch1 signaling by RNA interference can induce growth inhibition in HeLa cells. | 3.91e-05 | 2 | 218 | 2 | 17309564 | |
| Pubmed | 3.91e-05 | 2 | 218 | 2 | 18420801 | ||
| Pubmed | 3.91e-05 | 2 | 218 | 2 | 12897158 | ||
| Pubmed | 3.91e-05 | 2 | 218 | 2 | 31270208 | ||
| Pubmed | 3.91e-05 | 2 | 218 | 2 | 12185081 | ||
| Pubmed | 3.91e-05 | 2 | 218 | 2 | 24470632 | ||
| Pubmed | 3.91e-05 | 2 | 218 | 2 | 22134241 | ||
| Pubmed | 3.91e-05 | 2 | 218 | 2 | 12213084 | ||
| Pubmed | 3.91e-05 | 2 | 218 | 2 | 21195348 | ||
| Pubmed | 3.91e-05 | 2 | 218 | 2 | 8195215 | ||
| Pubmed | 3.91e-05 | 2 | 218 | 2 | 32966289 | ||
| Pubmed | 3.91e-05 | 2 | 218 | 2 | 2997781 | ||
| Pubmed | A conserved SREBP-1/phosphatidylcholine feedback circuit regulates lipogenesis in metazoans. | 3.91e-05 | 2 | 218 | 2 | 22035958 | |
| Pubmed | Differential expression of ets-1 and ets-2 proto-oncogenes during murine embryogenesis. | 3.91e-05 | 2 | 218 | 2 | 8183549 | |
| Pubmed | 3.91e-05 | 2 | 218 | 2 | 24277931 | ||
| Pubmed | 3.91e-05 | 2 | 218 | 2 | 21352396 | ||
| Pubmed | Prenatal molecular diagnosis of oculocutaneous albinism (OCA) in a large cohort of Israeli families. | 3.91e-05 | 2 | 218 | 2 | 19626598 | |
| Pubmed | The Notch1-Dll4 signaling pathway regulates mouse postnatal lymphatic development. | 3.91e-05 | 2 | 218 | 2 | 21700774 | |
| Pubmed | Neuronal L-type calcium channels open quickly and are inhibited slowly. | 3.91e-05 | 2 | 218 | 2 | 16267232 | |
| Pubmed | eEF2K inhibition blocks Aβ42 neurotoxicity by promoting an NRF2 antioxidant response. | 3.91e-05 | 2 | 218 | 2 | 27752775 | |
| Pubmed | 3.91e-05 | 2 | 218 | 2 | 34817668 | ||
| Pubmed | 3.91e-05 | 2 | 218 | 2 | 31676012 | ||
| Pubmed | 3.91e-05 | 2 | 218 | 2 | 25791711 | ||
| Pubmed | The mouse dead-end gene isoform alpha is necessary for germ cell and embryonic viability. | 3.91e-05 | 2 | 218 | 2 | 17291453 | |
| Pubmed | 3.91e-05 | 2 | 218 | 2 | 17846428 | ||
| Pubmed | DLL4 regulates NOTCH signaling and growth of T acute lymphoblastic leukemia cells in NOD/SCID mice. | 3.91e-05 | 2 | 218 | 2 | 25355291 | |
| Pubmed | 3.91e-05 | 2 | 218 | 2 | 24576892 | ||
| Pubmed | 3.91e-05 | 2 | 218 | 2 | 24356582 | ||
| Pubmed | 3.91e-05 | 2 | 218 | 2 | 10746781 | ||
| Pubmed | Structure and functional characterization of neuronal alpha 1E calcium channel subtypes. | 3.91e-05 | 2 | 218 | 2 | 8071363 | |
| Pubmed | 3.91e-05 | 2 | 218 | 2 | 3019221 | ||
| Cytoband | 17q25.1 | 4.41e-05 | 81 | 218 | 5 | 17q25.1 | |
| GeneFamily | Potassium voltage-gated channel subfamily J | 7.87e-06 | 16 | 151 | 4 | 276 | |
| GeneFamily | EF-hand domain containing | CAPN12 SWAP70 CETN3 DUOX1 CACNA1B CACNA1E EFCAB6 PLCH2 SDF4 PLCH1 | 1.57e-05 | 219 | 151 | 10 | 863 |
| GeneFamily | Calcium voltage-gated channel subunits | 6.06e-05 | 26 | 151 | 4 | 253 | |
| GeneFamily | Dyneins, axonemal | 3.56e-04 | 17 | 151 | 3 | 536 | |
| GeneFamily | WD repeat domain containing | 3.62e-04 | 262 | 151 | 9 | 362 | |
| GeneFamily | C3 and PZP like, alpha-2-macroglobulin domain containing | 2.40e-03 | 9 | 151 | 2 | 1234 | |
| GeneFamily | Alkylation repair homologs | 2.40e-03 | 9 | 151 | 2 | 401 | |
| GeneFamily | Pleckstrin homology domain containing|SH2 domain containing|C2 and RasGAP domain containing | 2.98e-03 | 10 | 151 | 2 | 830 | |
| Coexpression | GSE10240_CTRL_VS_IL17_AND_IL22_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_DN | CHEK1 GTF3C4 RNF157 PARP1 EEF2K NOTCH1 KIF22 SCAP PRKCE ELP2 ESPL1 | 9.18e-07 | 200 | 216 | 11 | M304 |
| Coexpression | VANOEVELEN_MYOGENESIS_SIN3A_TARGETS | 1.61e-05 | 221 | 216 | 10 | M2524 | |
| Coexpression | VANOEVELEN_MYOGENESIS_SIN3A_TARGETS | 1.81e-05 | 224 | 216 | 10 | MM959 | |
| CoexpressionAtlas | DevelopingKidney_e12.5_renal vesicle_emap-27679_k-means-cluster#1_top-relative-expression-ranked_1000 | CTU2 TAGAP NUDT8 DUS1L MKS1 CDC45 MDN1 MOGS NCAPD2 KIF22 CAD DYNC2I2 CHTF18 HYAL2 PCNT | 1.45e-05 | 412 | 208 | 15 | gudmap_developingKidney_e12.5_renal vesicle_1000_k1 |
| ToppCell | mild_COVID-19-NK_CD56bright|mild_COVID-19 / disease group, cell group and cell class (v2) | CAPN12 CD300A CSMD2 KCNJ12 NOTCH1 FRAS1 ZC3H12A CCDC39 PLCH2 HSH2D IL2RB | 1.47e-09 | 180 | 217 | 11 | d8b418edd807a51c0b5f4018b8b478dcc65892a7 |
| ToppCell | LPS_only-Endothelial-Endothelial-Gen_Cap|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | MAGI1 CD109 ETS1 PCDH17 EXOC3L1 DYNC1I1 DLL4 PKP4 CAV1 PREX2 CTNND1 | 3.07e-09 | 193 | 217 | 11 | af5108260783e69a7d67896c5bf64f862525926d |
| ToppCell | LPS-IL1RA-Endothelial|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | MAGI1 CD109 ETS1 PCDH17 EXOC3L1 DLL4 PKP4 CAV1 PRKCE EML1 CTNND1 | 3.24e-09 | 194 | 217 | 11 | 43f92b0533e26633dc94cce554045d641ef8fd76 |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | MAGI1 CD109 ETS1 PCDH17 EXOC3L1 DLL4 PKP4 CAV1 PRKCE EML1 CTNND1 | 3.24e-09 | 194 | 217 | 11 | 1d39d968730a7e85b6161c1c8a6bd38afe9bcad7 |
| ToppCell | LPS_only-Endothelial|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | MAGI1 CD109 ETS1 PCDH17 EXOC3L1 DLL4 PKP4 CAV1 PREX2 PRKCE CTNND1 | 3.24e-09 | 194 | 217 | 11 | 58f069efdefa0366033764446b9d6ffd4a17807e |
| ToppCell | LPS_only-Endothelial-Endothelial|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | MAGI1 CD109 ETS1 PCDH17 EXOC3L1 DLL4 PKP4 CAV1 PREX2 PRKCE CTNND1 | 3.24e-09 | 194 | 217 | 11 | bfd92ec75facb0ba55c31e5f2e089d983b3d0169 |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | MYH10 CSMD3 MAN1A2 KCNJ3 DYNC1I1 CACNA1B CACNA1C CACNA1D GALNT17 CADPS PRKCE | 3.61e-09 | 196 | 217 | 11 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | CD109 ETS1 ETS2 PCDH17 DLL4 MMP28 PKP4 CAV1 PREX2 CTNND1 HYAL2 | 4.46e-09 | 200 | 217 | 11 | b2d4e6f3e8e4da62e6b02758ab2ed8f505269f9a |
| ToppCell | mild_COVID-19-NK_CD56bright|World / disease group, cell group and cell class (v2) | CAPN12 CD300A KCNJ12 CACNA1C FRAS1 ZC3H12A CCDC39 PLCH2 HSH2D IL2RB | 2.42e-08 | 183 | 217 | 10 | 9a4899afac0f91203209392c5f67b3d0aa356b86 |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell__prolif|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.97e-08 | 187 | 217 | 10 | 35c382c0aabd46906113e5db30ea24bb8e658899 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.00e-08 | 193 | 217 | 10 | 02f633b016ab19bfa65bfd0cf32f000549a62148 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Gen_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | MAGI1 CD109 ETS1 PCDH17 EXOC3L1 PKP4 CAV1 PREX2 PRKCE CTNND1 | 4.00e-08 | 193 | 217 | 10 | 6e1982d089a9de628e6006d23ff78a223fbd9f47 |
| ToppCell | LPS-antiTNF-Endothelial|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.00e-08 | 193 | 217 | 10 | 5122b1ffba42de190061be34ecdc6176f84e56a3 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | MYH10 CSMD3 KCNJ3 DYNC1I1 CACNA1B CACNA1C CACNA1D GALNT17 CADPS PRKCE | 5.10e-08 | 198 | 217 | 10 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 |
| ToppCell | COVID-19-lung-Capillary_2|lung / Disease (COVID-19 only), tissue and cell type | MAGI1 CD109 ETS1 INO80D PCDH17 EXOC3L1 DLL4 PREX2 EML1 HYAL2 | 5.34e-08 | 199 | 217 | 10 | 793ce71b78a68033ef4419ed571e1dd86b40124f |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Endothelial|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | MAGI1 CD109 PCDH17 EXOC3L1 NOTCH1 DLL4 PKP4 CAV1 PREX2 HYAL2 | 5.34e-08 | 199 | 217 | 10 | f0bf75bfae7b288ecb6801be458b03ebd0108ea7 |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | CSMD3 MAN1A2 KCNJ3 DYNC1I1 CACNA1B CACNA1C CACNA1D GALNT17 CADPS PRKCE | 5.60e-08 | 200 | 217 | 10 | 48d801219bc771d6c7e151dc88ca4c179988de85 |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Alv_Cap|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 5.60e-08 | 200 | 217 | 10 | b7533c571eeea0cb3678e1a57d3dc036fa8d0f49 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Activated_Gen_Cap|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 5.60e-08 | 200 | 217 | 10 | 3585484c7e24e941708bee471ca607d8ccee74e6 | |
| ToppCell | LPS_only-Endothelial-Endothelial|LPS_only / Treatment groups by lineage, cell group, cell type | 5.60e-08 | 200 | 217 | 10 | 4bb609a284d4e6066f17470a1736076aa4a1f84c | |
| ToppCell | LPS_only-Endothelial|LPS_only / Treatment groups by lineage, cell group, cell type | 5.60e-08 | 200 | 217 | 10 | 81e76508c9050d533853d5fd2f3097b27613d836 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Activated_Gen_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 5.60e-08 | 200 | 217 | 10 | f15fffefe372005c33e31845982e2d2714ac26af | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Gen_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 5.60e-08 | 200 | 217 | 10 | a2b9d1cd291d17abddc3ee2e242121412c864b8b | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Adult / Lineage, Cell type, age group and donor | CAPN12 MAGI1 CPAMD8 DUOX1 ELAPOR1 SORCS2 DNAH5 MMP28 PITPNM3 | 1.13e-07 | 163 | 217 | 9 | e819a1d6d28290854aa0672b3a18fa9e293d8f23 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.15e-07 | 184 | 217 | 9 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.15e-07 | 184 | 217 | 9 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.15e-07 | 184 | 217 | 9 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | COVID-19-Epithelial_cells|COVID-19 / group, cell type (main and fine annotations) | 3.78e-07 | 188 | 217 | 9 | c9cdee6f8d42ee69f5fb335f25084603c511bd29 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.95e-07 | 189 | 217 | 9 | 203c80030df08ae112f9ae4043709f455d87ce89 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.31e-07 | 191 | 217 | 9 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.51e-07 | 192 | 217 | 9 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.71e-07 | 193 | 217 | 9 | 6a623acd1adad9a78eddc32ffedb16352ad3fdfa | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | MYH10 CSMD3 DYNC1I1 CACNA1C CACNA1D TGM2 GALNT17 CCBE1 LSAMP | 4.92e-07 | 194 | 217 | 9 | 011e14d9ed1393275f892060e7708ffadcd0767f |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.92e-07 | 194 | 217 | 9 | 0b9cd96fa0b616da7cc90e92ff71157e9bba518f | |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 5.13e-07 | 195 | 217 | 9 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW09-Macroglial-Glia_progenitor_cell|GW09 / Sample Type, Dataset, Time_group, and Cell type. | 5.36e-07 | 196 | 217 | 9 | 7be50b9156394dea44d7b8b476d4dd516abfafae | |
| ToppCell | Bronchial-NucSeq-Endothelial-Endothelia_vascular-VE_capillary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.59e-07 | 197 | 217 | 9 | 81718164c9802ee20c860ffbda7e62d5e9a76f16 | |
| ToppCell | Tracheal-NucSeq-Endothelial-Endothelia_vascular|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.83e-07 | 198 | 217 | 9 | f7aa809040fa9f5782b92eec1f289d690eb5c7bd | |
| ToppCell | Adult-Mesenchymal|Adult / Lineage, Cell type, age group and donor | MYH10 PDLIM3 CACNA1C CACNA1D ANK2 CCDC39 GALNT17 CCBE1 LSAMP | 5.83e-07 | 198 | 217 | 9 | 26e55b409db2a1637c95fae7c54b0abea1ef550c |
| ToppCell | COVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 5.83e-07 | 198 | 217 | 9 | df3de77216f5c5d6141ec44d01c56b942f611838 | |
| ToppCell | ILEUM-non-inflamed-(7)_ACKR1+_endothelial_cells|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 5.83e-07 | 198 | 217 | 9 | f8a6a75c9f2fbe32a22b14b6a029411c73c09f68 | |
| ToppCell | LPS_only-Epithelial_airway-airway_epithelial-Ciliated|LPS_only / Treatment groups by lineage, cell group, cell type | 5.83e-07 | 198 | 217 | 9 | 6d90b541fde357fbb40f8f7d4e8628a48b679718 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | CSMD3 KCNJ3 DYNC1I1 CACNA1B CACNA1C CACNA1D GALNT17 CADPS PRKCE | 5.83e-07 | 198 | 217 | 9 | c01091ef18e096d792ea2a7a715764a5b215355f |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | CSMD3 KCNJ3 DYNC1I1 CACNA1B CACNA1C CACNA1D GALNT17 CADPS PRKCE | 5.83e-07 | 198 | 217 | 9 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | MYH10 CSMD3 KCNJ3 DYNC1I1 CACNA1B CACNA1C GALNT17 CADPS PRKCE | 5.83e-07 | 198 | 217 | 9 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 |
| ToppCell | COVID-19-lung-Capillary_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.83e-07 | 198 | 217 | 9 | 45419f2804b4be79bae6632e71c54e1af482d115 | |
| ToppCell | IPF-Endothelial-VE_Peribronchial|Endothelial / Disease state, Lineage and Cell class | 5.83e-07 | 198 | 217 | 9 | b8bd1ba268480f54451648e01631b615a3401144 | |
| ToppCell | wk_15-18-Endothelial-Blood_vessel_endothelial-intermediate_cap|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 5.83e-07 | 198 | 217 | 9 | 75270600b5b29187dfa86f01f8f927ae0621cda4 | |
| ToppCell | COVID-19-kidney-Glomerular_EC|kidney / Disease (COVID-19 only), tissue and cell type | 6.08e-07 | 199 | 217 | 9 | fffd2f9042b55531dac4e5b463b5cee80402e7bb | |
| ToppCell | wk_20-22-Endothelial-Blood_vessel_endothelial|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 6.08e-07 | 199 | 217 | 9 | 243b7c72f83c12a34d8ea300fca63b04216268a4 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Neuron-Neuron|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | VWA5B2 CSMD3 DYNC1I1 CACNA1B CACNA1E FRAS1 OCA2 GALNT17 PITPNM3 | 6.34e-07 | 200 | 217 | 9 | 2f481e2fd248c02a5aa2e0248c16808df142fed2 |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Neuron-Neuron-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | VWA5B2 CSMD3 DYNC1I1 CACNA1B CACNA1E FRAS1 OCA2 GALNT17 PITPNM3 | 6.34e-07 | 200 | 217 | 9 | bd4b9f6b37f4a3c960c4149cf0cfd2caf3327d2d |
| ToppCell | Control_saline-Endothelial-Endothelial-Gen_Cap|Control_saline / Treatment groups by lineage, cell group, cell type | 6.34e-07 | 200 | 217 | 9 | 3b97920e1e6e2f09ddba2a861baa9c00c2970f4c | |
| ToppCell | LPS_only-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS_only / Treatment groups by lineage, cell group, cell type | 6.34e-07 | 200 | 217 | 9 | b1fadb2b5e37e0f51e079d8409c2647eef68dc3b | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 6.34e-07 | 200 | 217 | 9 | 58a7ece7dfdf6c46f2a50cbcb580574dec14c748 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 6.34e-07 | 200 | 217 | 9 | d01cec331be3b03cef80e9536fc531285bcf00f6 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 6.34e-07 | 200 | 217 | 9 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | LPS_only-Endothelial-Endothelial-Gen_Cap|LPS_only / Treatment groups by lineage, cell group, cell type | 6.34e-07 | 200 | 217 | 9 | eb94a5111ef0e903ee5be9f7efe571b4e6d5fce1 | |
| ToppCell | Lung_Parenchyma-Severe-Endothelial-Endothelial-Endothelial-1|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.34e-07 | 200 | 217 | 9 | 27507c4b41d45c7cc50e4993169c0302be22ee34 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 6.34e-07 | 200 | 217 | 9 | a1fa6bae5a688faf488d6925cd3fad725dfa916b | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 6.34e-07 | 200 | 217 | 9 | 89a6da2bdedc6b1ad0675c8753bf2b763a99af6a | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Neuron|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | VWA5B2 CSMD3 DYNC1I1 CACNA1B CACNA1E FRAS1 OCA2 GALNT17 PITPNM3 | 6.34e-07 | 200 | 217 | 9 | dc674124475edf83908b51a4e1454bc2dc4f06fa |
| ToppCell | Parenchyma_COVID-19-Endothelial-TX-Endothelial-1|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 6.34e-07 | 200 | 217 | 9 | b65fb8d378abd91cdabf5faac5f4b90d527f8c44 | |
| ToppCell | Lung_Parenchyma-Severe-Endothelial-Endothelial-Endothelial-1-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.34e-07 | 200 | 217 | 9 | 2cb6e35add34b9dc564ebcf5d3cbc761325ca9f4 | |
| ToppCell | E16.5-samps-Epithelial-Alveolar_epithelial_precursor-Noncycling_AT1_Precursor|E16.5-samps / Age Group, Lineage, Cell class and subclass | 9.18e-07 | 154 | 217 | 8 | 8a643d91896af9b630a715fb284c1523d01ad1a3 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D122|Adult / Lineage, Cell type, age group and donor | 1.06e-06 | 157 | 217 | 8 | 31d1bd9138c60e8485664ec4144f987226e3eef9 | |
| ToppCell | Adult-Mesenchymal-vascular_smooth_muscle_cell-D175|Adult / Lineage, Cell type, age group and donor | 1.69e-06 | 167 | 217 | 8 | c4e321bb87512ea839f324c92c0f1afea891483f | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.85e-06 | 169 | 217 | 8 | c7fc3a8c44f07c557b60d469717b66e2f5863d38 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_neuroendocrine_cell_(PNEC)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.85e-06 | 169 | 217 | 8 | b6b5bb6408c1305a00719e1b88a5e1202081faf3 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.29e-06 | 174 | 217 | 8 | f1fe1f4216748a9562dd03bd48c70b23c7ff4d1d | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Epithelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.72e-06 | 178 | 217 | 8 | 6178706db4a855d72abc156537604d575624df56 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.72e-06 | 178 | 217 | 8 | fcbbcc44271515de1969b4732b6441c012693d5f | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Epithelial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.72e-06 | 178 | 217 | 8 | f02076ece0fa899e620971c887ad4da7f48684ed | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.72e-06 | 178 | 217 | 8 | f5ed4a6e3eb8056b1be1fb311021710c95bdf888 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.08e-06 | 181 | 217 | 8 | 30729f0364f719c044712a51453e22dc2c1a232b | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.08e-06 | 181 | 217 | 8 | 9ede19228ba5c0668a9c06c915510b95585216ef | |
| ToppCell | E18.5-samps-Endothelial-Mature_fetal_endothelial-endothelial_cells_A|E18.5-samps / Age Group, Lineage, Cell class and subclass | 3.20e-06 | 182 | 217 | 8 | ea4f6c8f600ffe9f8e0609637b3371a5ac48ca03 | |
| ToppCell | COVID-19-Heart-CM_4|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.34e-06 | 183 | 217 | 8 | 2902b6e8aa9a6f62bc1a792c971ab7f651a8e676 | |
| ToppCell | COVID-19-Heart-CM_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.47e-06 | 184 | 217 | 8 | e737f0f14c49b07bbb04a165083ac32210bc5690 | |
| ToppCell | COVID-19-Heart-CM_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.62e-06 | 185 | 217 | 8 | 549eeb521c3985bff396ea0f202db21822efa51f | |
| ToppCell | 10x3'2.3-week_17-19-Endothelial-stroma-proliferating_EC|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.76e-06 | 186 | 217 | 8 | a844d4f79e0ad5d6c60a4488ffd8f4f21b7eed04 | |
| ToppCell | facs-Aorta-Heart-3m-Endothelial-nan|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.92e-06 | 187 | 217 | 8 | df0279b7e94e26f5541b0e2a0ce56befa96ec8ca | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.92e-06 | 187 | 217 | 8 | 4ae7465174e0295d2c3b614b321a3b2f514dd22a | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 3.92e-06 | 187 | 217 | 8 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 4.07e-06 | 188 | 217 | 8 | 6d249fe92d51a19da19ec14bb2262d394255d577 | |
| ToppCell | facs-Pancreas-Endocrine-24m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.07e-06 | 188 | 217 | 8 | a91443aa8fa8fa87f7501c59219daa0305bd0bbf | |
| ToppCell | Control-Epithelial_cells|Control / group, cell type (main and fine annotations) | 4.07e-06 | 188 | 217 | 8 | 707ebf76cc6fb600b2f07793cf4ea9482c0de79d | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.24e-06 | 189 | 217 | 8 | 6463890d8dbee4bc198f91628a5f784970de786a | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.40e-06 | 190 | 217 | 8 | bf9bc57a605c7e3979bc4f7260e6fb92c3eb8690 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Alv_Cap|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.40e-06 | 190 | 217 | 8 | 474cbbab8f3b0a6881fa6c92edb78e43999f9ab0 | |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | 4.40e-06 | 190 | 217 | 8 | 3a42a9b98d954685d38a741f44545898d0e3e9ce | |
| ToppCell | COVID-19-Heart-CM_4|Heart / Disease (COVID-19 only), tissue and cell type | 4.40e-06 | 190 | 217 | 8 | 3729648a17093b438398b82e32bbccc3af7b8c5d | |
| ToppCell | ASK454-Mesenchymal|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 4.58e-06 | 191 | 217 | 8 | e30ae7a12439f8a79820b13f03e822c1223fd0cb | |
| ToppCell | facs-SCAT-Fat-3m-Endothelial-endothelial_cell|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.58e-06 | 191 | 217 | 8 | 6b9bbf4a63d4e9a8075bb06c2aa644fcf4ee88b8 | |
| ToppCell | facs-Heart-RV-3m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.58e-06 | 191 | 217 | 8 | 84ebb9f8e975acc88aa600c08a8aa791256948a6 | |
| ToppCell | facs-SCAT-Fat-3m-Endothelial-nan|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.58e-06 | 191 | 217 | 8 | a0018f88f7132477cc467ee15db029a585290595 | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|LA / Chamber and Cluster_Paper | 4.58e-06 | 191 | 217 | 8 | 5d1b674eb7703830b7ce8bbeac3363cabd0e6ae9 | |
| ToppCell | ASK454-Mesenchymal-Fibroblast|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 4.58e-06 | 191 | 217 | 8 | 1726add3f392a061536b7aff72ba84303f4a0b1f | |
| ToppCell | facs-SCAT-Fat-3m-Endothelial|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.58e-06 | 191 | 217 | 8 | 90f0c193dce267a4f1a9b2501f636dafd0a34cf7 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.75e-06 | 136 | 217 | 7 | 7cd22169fb71c6caf9feb203ad98be8480a54fba | |
| Drug | AC1L1GTQ | 7.38e-07 | 54 | 215 | 7 | CID000003836 | |
| Disease | Duchenne muscular dystrophy (implicated_via_orthology) | 5.23e-06 | 36 | 208 | 5 | DOID:11723 (implicated_via_orthology) | |
| Disease | Ciliopathies | 1.35e-05 | 110 | 208 | 7 | C4277690 | |
| Disease | Malignant neoplasm of breast | CTU2 MAN2C1 CD109 ETS2 CHEK1 ZNF25 PARP1 FASN NAA25 PER3 ELAPOR1 EXOC3L1 FTO NOTCH1 ANK2 DLL4 OCA2 NUP214 CAV1 TGM2 TXNDC15 | 2.61e-05 | 1074 | 208 | 21 | C0006142 |
| Disease | lung large cell carcinoma (biomarker_via_orthology) | 4.95e-05 | 2 | 208 | 2 | DOID:4556 (biomarker_via_orthology) | |
| Disease | lung small cell carcinoma (biomarker_via_orthology) | 4.95e-05 | 2 | 208 | 2 | DOID:5409 (biomarker_via_orthology) | |
| Disease | Mammary Carcinoma, Human | CTU2 MAN2C1 CD109 ETS2 CHEK1 PARP1 FASN PER3 FTO NOTCH1 DLL4 CAV1 TGM2 | 9.91e-05 | 525 | 208 | 13 | C4704874 |
| Disease | Mammary Neoplasms, Human | CTU2 MAN2C1 CD109 ETS2 CHEK1 PARP1 FASN PER3 FTO NOTCH1 DLL4 CAV1 TGM2 | 9.91e-05 | 525 | 208 | 13 | C1257931 |
| Disease | Mammary Neoplasms | CTU2 MAN2C1 CD109 ETS2 CHEK1 PARP1 FASN PER3 FTO NOTCH1 DLL4 CAV1 TGM2 | 1.03e-04 | 527 | 208 | 13 | C1458155 |
| Disease | age-related hearing impairment | 1.10e-04 | 324 | 208 | 10 | EFO_0005782 | |
| Disease | Primary ciliary dyskinesia | 1.18e-04 | 36 | 208 | 4 | cv:C0008780 | |
| Disease | Breast Carcinoma | CTU2 MAN2C1 CD109 ETS2 CHEK1 PARP1 FASN PER3 FTO NOTCH1 DLL4 CAV1 TGM2 | 1.26e-04 | 538 | 208 | 13 | C0678222 |
| Disease | familial hemiplegic migraine 1 (implicated_via_orthology) | 1.48e-04 | 3 | 208 | 2 | DOID:0111181 (implicated_via_orthology) | |
| Disease | Meckel syndrome type 1 | 2.61e-04 | 18 | 208 | 3 | C3714506 | |
| Disease | lung adenocarcinoma (biomarker_via_orthology) | 2.94e-04 | 4 | 208 | 2 | DOID:3910 (biomarker_via_orthology) | |
| Disease | Timothy syndrome (implicated_via_orthology) | 2.94e-04 | 4 | 208 | 2 | DOID:0060173 (implicated_via_orthology) | |
| Disease | migraine (implicated_via_orthology) | 2.94e-04 | 4 | 208 | 2 | DOID:6364 (implicated_via_orthology) | |
| Disease | neck circumference | 3.08e-04 | 19 | 208 | 3 | EFO_0011043 | |
| Disease | hydrocephalus (implicated_via_orthology) | 3.08e-04 | 19 | 208 | 3 | DOID:10908 (implicated_via_orthology) | |
| Disease | Primary Ciliary Dyskinesia | 3.37e-04 | 47 | 208 | 4 | C4551720 | |
| Disease | Global developmental delay | 3.72e-04 | 133 | 208 | 6 | C0557874 | |
| Disease | oculocutaneous albinism (implicated_via_orthology) | 4.88e-04 | 5 | 208 | 2 | DOID:0050632 (implicated_via_orthology) | |
| Disease | acyl-CoA-binding domain-containing protein 7 measurement | 4.88e-04 | 5 | 208 | 2 | EFO_0801343 | |
| Disease | muscular disease (implicated_via_orthology) | 4.88e-04 | 5 | 208 | 2 | DOID:0080000 (implicated_via_orthology) | |
| Disease | Colorectal Carcinoma | CPAMD8 PAIP2 CD109 CSMD3 PARP1 DNAH8 CAD ANK2 STK32C PREX2 TGM2 ABCG1 PRKCE SDF4 | 4.94e-04 | 702 | 208 | 14 | C0009402 |
| Disease | Schizophrenia | MAGI1 SREBF1 CHEK1 CSMD2 PCDH17 TYR EML5 KCNJ3 CACNA1B CACNA1C ZSCAN31 CAV1 TGM2 LSAMP SDF4 PCNT | 5.63e-04 | 883 | 208 | 16 | C0036341 |
| Disease | colorectal health | 5.84e-04 | 201 | 208 | 7 | EFO_0008460 | |
| Disease | Congenital defect of skull and scalp | 7.28e-04 | 6 | 208 | 2 | C2931779 | |
| Disease | Aplasia Cutis Congenita | 7.28e-04 | 6 | 208 | 2 | C0282160 | |
| Disease | Adams Oliver syndrome | 7.28e-04 | 6 | 208 | 2 | C0265268 | |
| Disease | Adams-Oliver syndrome 1 | 7.28e-04 | 6 | 208 | 2 | C4551482 | |
| Disease | Adams-Oliver syndrome (is_implicated_in) | 7.28e-04 | 6 | 208 | 2 | DOID:0060227 (is_implicated_in) | |
| Disease | Disorder of eye | 8.00e-04 | 212 | 208 | 7 | C0015397 | |
| Disease | transient cerebral ischemia (biomarker_via_orthology) | 8.92e-04 | 157 | 208 | 6 | DOID:224 (biomarker_via_orthology) | |
| Disease | Frontotemporal dementia | 1.01e-03 | 7 | 208 | 2 | C0338451 | |
| Disease | Semantic Dementia | 1.01e-03 | 7 | 208 | 2 | C0338462 | |
| Disease | Developmental regression | 1.01e-03 | 7 | 208 | 2 | C1836830 | |
| Disease | gamma-glutamylmethionine measurement | 1.01e-03 | 7 | 208 | 2 | EFO_0021141 | |
| Disease | hereditary ataxia (implicated_via_orthology) | 1.01e-03 | 7 | 208 | 2 | DOID:0050951 (implicated_via_orthology) | |
| Disease | Albinism, Oculocutaneous | 1.01e-03 | 7 | 208 | 2 | C0078918 | |
| Disease | Oculocutaneous albinism | 1.01e-03 | 7 | 208 | 2 | cv:C0078918 | |
| Disease | non-alcoholic fatty liver disease (biomarker_via_orthology) | 1.16e-03 | 65 | 208 | 4 | DOID:0080208 (biomarker_via_orthology) | |
| Disease | cigarettes per day measurement | 1.16e-03 | 438 | 208 | 10 | EFO_0006525 | |
| Disease | cognitive function measurement | MAGI1 CSMD3 ZP3 PCDH17 LRFN2 GANAB PDLIM3 KCNJ3 KCNJ4 MYO18B DNAH5 CACNA1C CACNA1D CACNA1E CXorf38 DLL4 ADGRA2 GALNT17 ZNF335 HYDIN SOS1 | 1.28e-03 | 1434 | 208 | 21 | EFO_0008354 |
| Disease | alcohol consumption measurement | CAPN12 MAGI1 MYH10 PSEN1 CSMD3 INO80D KCNJ3 FTO DNAH5 CACNA1C CACNA1D CACNA1E CAD WRAP53 STT3B PIGQ CADPS PLCH1 SENP7 | 1.33e-03 | 1242 | 208 | 19 | EFO_0007878 |
| Disease | Aqueductal Stenosis | 1.35e-03 | 8 | 208 | 2 | C2936786 | |
| Disease | Alzheimer disease | 1.35e-03 | 8 | 208 | 2 | cv:C0002395 | |
| Disease | switch-associated protein 70 measurement | 1.35e-03 | 8 | 208 | 2 | EFO_0802107 | |
| Disease | Primary Progressive Nonfluent Aphasia | 1.35e-03 | 8 | 208 | 2 | C0751706 | |
| Disease | leukopenia, response to thiopurine | 1.35e-03 | 8 | 208 | 2 | EFO_0004233, EFO_0006317 | |
| Disease | breast size | 1.45e-03 | 69 | 208 | 4 | EFO_0004884 | |
| Disease | Nonorganic psychosis | 1.45e-03 | 69 | 208 | 4 | C0349204 | |
| Disease | cutaneous melanoma | 1.70e-03 | 121 | 208 | 5 | EFO_0000389 | |
| Disease | hemangiopericytoma (is_marker_for) | 1.72e-03 | 9 | 208 | 2 | DOID:264 (is_marker_for) | |
| Disease | Behavioral variant of frontotemporal dementia | 1.72e-03 | 9 | 208 | 2 | C4011788 | |
| Disease | melanoma | 2.03e-03 | 126 | 208 | 5 | EFO_0000756 | |
| Disease | Anemia, Sickle Cell | 2.14e-03 | 10 | 208 | 2 | C0002895 | |
| Disease | Meckel-Gruber syndrome | 2.14e-03 | 10 | 208 | 2 | cv:C0265215 | |
| Disease | hair colour measurement, eye colour measurement, skin pigmentation measurement | 2.14e-03 | 10 | 208 | 2 | EFO_0007009, EFO_0007822, EFO_0009764 | |
| Disease | Bipolar Disorder | MAGI1 PER3 SORCS2 DNAH8 CACNA1B CACNA1C CACNA1D TGM2 IL2RB PCNT | 2.18e-03 | 477 | 208 | 10 | C0005586 |
| Disease | Developmental delay (disorder) | 2.25e-03 | 37 | 208 | 3 | C0424605 | |
| Disease | Cardiomyopathies | 2.33e-03 | 130 | 208 | 5 | C0878544 | |
| Disease | cortical thickness | VWA5B2 MAGI1 CPAMD8 SREBF1 CMAS PCDH17 DUOX1 ADAMTS20 SMG6 MCPH1 ACTRT2 ADGRA2 ABCG1 BAZ1A CADPS EML1 PLCH1 | 2.42e-03 | 1113 | 208 | 17 | EFO_0004840 |
| Disease | pigmentation disease (is_implicated_in) | 2.61e-03 | 11 | 208 | 2 | DOID:10123 (is_implicated_in) | |
| Disease | R-warfarin measurement | 2.85e-03 | 265 | 208 | 7 | EFO_0803324 | |
| Disease | Profound Mental Retardation | 3.11e-03 | 139 | 208 | 5 | C0020796 | |
| Disease | Mental deficiency | 3.11e-03 | 139 | 208 | 5 | C0917816 | |
| Disease | Mental Retardation, Psychosocial | 3.11e-03 | 139 | 208 | 5 | C0025363 | |
| Disease | response to anticonvulsant | 3.11e-03 | 85 | 208 | 4 | GO_0036277 | |
| Disease | retinopathy of prematurity (biomarker_via_orthology) | 3.12e-03 | 12 | 208 | 2 | DOID:13025 (biomarker_via_orthology) | |
| Disease | Alzheimer disease, polygenic risk score | BMS1 ABCA7 KCNJ3 SLC4A9 CACNA1E FRAS1 LDLR TREM2 LSAMP PLCH1 HYDIN | 3.12e-03 | 586 | 208 | 11 | EFO_0030082, MONDO_0004975 |
| Disease | Dystonia | 3.25e-03 | 86 | 208 | 4 | C0013421 | |
| Disease | Obesity | 3.43e-03 | 205 | 208 | 6 | C0028754 | |
| Disease | nevus count, cutaneous melanoma | 3.97e-03 | 91 | 208 | 4 | EFO_0000389, EFO_0004632 | |
| Disease | skin melanoma (is_implicated_in) | 4.26e-03 | 14 | 208 | 2 | DOID:8923 (is_implicated_in) | |
| Disease | tetralogy of Fallot (implicated_via_orthology) | 4.26e-03 | 14 | 208 | 2 | DOID:6419 (implicated_via_orthology) | |
| Disease | Kartagener syndrome (implicated_via_orthology) | 4.26e-03 | 14 | 208 | 2 | DOID:0050144 (implicated_via_orthology) | |
| Disease | Intellectual Disability | 4.65e-03 | 447 | 208 | 9 | C3714756 | |
| Disease | Kidney Failure, Chronic | 4.73e-03 | 48 | 208 | 3 | C0022661 | |
| Disease | total blood protein measurement | 4.79e-03 | 449 | 208 | 9 | EFO_0004536 | |
| Disease | Body Weight | 4.89e-03 | 15 | 208 | 2 | C0005910 | |
| Disease | Autosomal recessive primary microcephaly | 4.89e-03 | 15 | 208 | 2 | cv:C3711387 | |
| Disease | primary autosomal recessive microcephaly (is_implicated_in) | 5.56e-03 | 16 | 208 | 2 | DOID:0070296 (is_implicated_in) | |
| Disease | Psychotic Disorders | 5.75e-03 | 101 | 208 | 4 | C0033975 | |
| Disease | monokine induced by gamma interferon measurement | 5.92e-03 | 52 | 208 | 3 | EFO_0008236 | |
| Disease | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 6.24e-03 | 53 | 208 | 3 | C1961099 | |
| Disease | non-alcoholic steatohepatitis (biomarker_via_orthology) | 6.27e-03 | 17 | 208 | 2 | DOID:0080547 (biomarker_via_orthology) | |
| Disease | Peripheral Nervous System Diseases | 6.58e-03 | 54 | 208 | 3 | C4721453 | |
| Disease | sphingosine 1-phosphate measurement | 7.02e-03 | 18 | 208 | 2 | EFO_0800185 | |
| Disease | age at onset, Parkinson disease | 7.02e-03 | 18 | 208 | 2 | EFO_0004847, MONDO_0005180 | |
| Disease | borna disease (biomarker_via_orthology) | 7.02e-03 | 18 | 208 | 2 | DOID:5154 (biomarker_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| REFAWRDPELPEVIH | 521 | Q99569 | |
| ERGSAIDPHLDDAWL | 161 | Q9NXW9 | |
| GPELEAADAFALLHW | 326 | Q86VI1 | |
| VGDDTTRLEIWIHPS | 846 | Q86US8 | |
| PEDLAELWGHGVSEA | 136 | Q8WVB6 | |
| TVHDGIWDAELPRAK | 31 | Q14236 | |
| EEKLEVAAGRWSAPH | 106 | Q96Q91 | |
| PEELWEAVVGAAERF | 6 | Q96B36 | |
| TWTELEDRDGRVYPH | 21 | Q9HA82 | |
| FRAVDPDGDGHVSWD | 146 | Q9BRK5 | |
| LFGEGIVESLIHAWE | 261 | Q6P2P2 | |
| EVHDVLRIWDGPVES | 1321 | Q7Z408 | |
| DTEASHDILRVWDGP | 1461 | Q7Z407 | |
| LGPHHLDEFVRVWAE | 1736 | Q15878 | |
| RREFHAEPVDVWSCG | 181 | O14757 | |
| DLGGDAEVNPFLWHR | 356 | P45844 | |
| LHSPFERGLITGWDD | 71 | Q8TDY3 | |
| AVSLRHWAEGAEPVA | 696 | Q96PE1 | |
| HSGATRLAWEEIDTP | 161 | Q6ZS02 | |
| LGDVGFWVERTPVHE | 11 | Q8WXK3 | |
| SLIIEAWHAPGDDLR | 116 | Q9NR61 | |
| LFEGRSPAVWELAEE | 241 | Q6P1R4 | |
| SPGLFHRLDEDWDSA | 16 | P18850 | |
| EEFQDWPIVRIAAHL | 6 | Q96PN6 | |
| IHGLFETQEWEEGLD | 126 | Q96PN6 | |
| RFLVEAPHDWDLEEV | 736 | Q14692 | |
| VIAEPEGTHSFDGIW | 71 | Q03135 | |
| LGPHHLDEFIRVWAE | 1721 | Q00975 | |
| DALQWSRHPATVEGE | 86 | Q8IXJ9 | |
| EVHLGTPERGAWESD | 106 | P59510 | |
| EHRFWAGVVFLGPED | 431 | Q8IZY2 | |
| LVVELVRHDDSWPFL | 1441 | Q9NRL2 | |
| WLRDFHDPIVEVEVS | 116 | Q08708 | |
| LAELHWEDGFAIPVA | 6 | Q9UFE4 | |
| FSGWAHLTEVDPDEE | 101 | O43374 | |
| GDRPSLTHVVEWIDF | 371 | Q04671 | |
| EEEEEHEWFIPARDL | 66 | Q9BPZ3 | |
| SSGEIRTLHPFWEDV | 641 | O14917 | |
| WEPQELGAVRSHLSD | 91 | Q9H1K0 | |
| FSGWAHLTEVDPDEE | 101 | C9J798 | |
| VLREHEIGEWEAFSL | 181 | Q86WH2 | |
| TREELGLAVPEEHVW | 86 | Q8WV74 | |
| GLQHDDDSVDSPRWL | 71 | P26045 | |
| HPDVEVDGFSELRWD | 66 | P09874 | |
| EILWGHRFEPVVFEE | 311 | P48050 | |
| HSVPEDIFDTRPIWD | 3526 | Q01484 | |
| EDHVLVEDVRDFWPG | 396 | Q9NRD9 | |
| TFIRDLHWPEEEFGK | 1076 | Q9ULU8 | |
| IEVPGDDWHCLRRED | 276 | Q8N612 | |
| ECNRLHPAEEGDFWA | 561 | Q6Y2X3 | |
| DAALGGPREHALDWD | 81 | Q96EL1 | |
| LFVETVDFWGDPHAL | 91 | Q86WK9 | |
| QLRPVGELSWADIDH | 406 | Q12891 | |
| EIDTSRLFEWHDGPL | 1441 | Q9NU22 | |
| WDGLDCAEHVPERLA | 1556 | P46531 | |
| EDREWHESFSLVLGP | 3116 | Q86XX4 | |
| HTEELDSELELPAGW | 351 | Q96QZ7 | |
| SLELGHWISEEPFEL | 716 | Q8NEM0 | |
| WHLETADRVDIPVSF | 1481 | Q16787 | |
| IFWVIAVAHGDLEPA | 101 | Q14500 | |
| ILWGHRFEPVLFEEK | 321 | Q14500 | |
| SDWVAVRPHVFDERE | 11 | Q8N9B5 | |
| EEVAHWFLPREHIID | 371 | O60551 | |
| IEDSLGERIWVDSPH | 231 | Q8N201 | |
| EDGWHSFLPEQEFEL | 121 | Q96QG7 | |
| FEALIEREWLQAGHP | 361 | Q96QG7 | |
| SEDERLQWHLPEGAA | 246 | Q96H55 | |
| SEDDSHLEGRDPDIW | 256 | Q9C0B1 | |
| STDHEEEGEHTWRLP | 221 | Q8NDA2 | |
| EEGEHTWRLPFDPSL | 226 | Q8NDA2 | |
| RHFEDWIDLEPEGRV | 111 | Q02156 | |
| GIRFDEWDELPHGFA | 121 | Q6UXG2 | |
| DSGHEFEWEDELPRA | 136 | Q7Z465 | |
| DVGELAVPHNDEWTR | 606 | O14576 | |
| EDPLLWRTGLTDDTH | 251 | Q96EX3 | |
| DLFPEESGFEHAWRE | 321 | Q9H501 | |
| LAPDFVGDILWEHLE | 116 | P14921 | |
| VWVPSELHGFEAAAL | 56 | Q7Z406 | |
| IAHEGDPAWRSAVLA | 1891 | Q96RV3 | |
| EESGERWSPEFHLQR | 21 | P56645 | |
| WTLTPEFLAEHRIDF | 151 | P49585 | |
| REPSIDLLQAFVEHW | 16 | Q86V87 | |
| VLGIFWVGAREISHD | 86 | Q8NGK0 | |
| WRELHGPFSQVEDLE | 621 | Q14807 | |
| APDFVGDILWEHLEQ | 151 | P15036 | |
| DGIVHFETREALPTW | 356 | Q9BT78 | |
| DWVRRQPVLDFESGH | 221 | Q5TAQ9 | |
| HWDRISELTGTPFDV | 1361 | Q96JB1 | |
| HVVDWARDGDPLEKL | 351 | Q6UWB1 | |
| FVFELSGEHWTELPD | 101 | Q9BYS8 | |
| ESDHPVRVLDVLWIG | 236 | P35658 | |
| WVDDFPLHRSACEGD | 286 | O00522 | |
| PEWFFSTIRHHEGVE | 171 | Q8TDV0 | |
| VETSALGHEWRLEPS | 626 | O95613 | |
| VPEWFHGAISREDAE | 31 | Q96JZ2 | |
| AAESLDELHWAPELG | 636 | Q13724 | |
| DELHWAPELGVFADF | 641 | Q13724 | |
| DWPVVTLIAEDDRHY | 326 | Q96BN8 | |
| DEAGLEVHQFWPLVE | 61 | Q13467 | |
| IHGLFLEGARWDPEA | 4166 | Q9P2D7 | |
| HVFQIPEELLGLWDS | 451 | Q6ZSI9 | |
| EFWDPGRVIHSELQG | 1026 | Q6YHK3 | |
| PVSGWQELETAFLEH | 51 | O75419 | |
| EETPAGAWARATHLV | 616 | Q14674 | |
| QLPHFRVESFSEDEW | 901 | Q8NFZ0 | |
| LAPEHEVREDDVGWD | 161 | Q96FT9 | |
| EGEHWEGPEFITLEA | 4666 | Q4G0P3 | |
| DEWERDLHFPESFAG | 586 | Q53HC5 | |
| TRDWSILGPHHLDEF | 1531 | Q13936 | |
| DKLELRTEPGFHWVI | 196 | P49184 | |
| RTEPGFHWVIADGED | 201 | P49184 | |
| PFLLAWDSVEEIVHD | 486 | Q5THR3 | |
| GPMETFEDLWQRHLE | 146 | I3L3R5 | |
| GKPEALWVEERFTAH | 821 | O14638 | |
| DWGEEVELNSPRTTH | 501 | Q9Y3X0 | |
| ADVPEHFRGRVSIWA | 306 | Q8IZJ3 | |
| HTWTYREEPEDGDRE | 31 | Q6UXH8 | |
| EQSWFPAVGHERQEE | 161 | Q6P2H3 | |
| EFEARTLSPGHTWEE | 166 | P14784 | |
| IFFEDPVVVRWDAEG | 446 | Q6TDU7 | |
| DAHVEFTAGWAEPVL | 246 | Q6IS24 | |
| FNEVVTDWILERDPH | 86 | O15182 | |
| LSQEFESHWPEIAER | 136 | Q7Z601 | |
| FWEGLDGSRVLVHFP | 411 | Q9NTJ4 | |
| GDDLLPLDHWVFNTE | 606 | O60476 | |
| WVVLTLDGRDGHEVA | 306 | Q8IYX4 | |
| DLFPHLGLDWSEESG | 316 | Q53TQ3 | |
| SDWAVHIPEEDQRDG | 211 | Q8TB03 | |
| PDPWAEFHLEDIATE | 96 | O00418 | |
| DAVGHRPVWDKIIED | 571 | O00423 | |
| LEWTRLVDEPGHCAD | 626 | Q9HC35 | |
| APGHTDRIFDISWDL | 146 | Q05BV3 | |
| REWTPEIVISGHFDG | 376 | Q6IA86 | |
| WDDSFPEGPERLHAI | 101 | Q9UBN7 | |
| WGAFRHFLLEEDKPE | 1511 | P49327 | |
| DWERFHADPDIIGTI | 181 | Q12770 | |
| TRDWSILGPHHLDEF | 1471 | Q01668 | |
| ALTDEVIIPHSGWER | 496 | O60716 | |
| GFPWHVVALEEVFSL | 141 | Q2VPK5 | |
| VWIPSERHGFEAASI | 36 | P35580 | |
| KEADDVGPRAELEHW | 276 | Q8TE73 | |
| HQDWSEEEEGRTVVP | 561 | A6NGG8 | |
| WGADPHILAKERESA | 146 | O14593 | |
| HFWEVAADGNVSEPR | 346 | Q9H239 | |
| IFWVIAVAHGDLEPA | 101 | B7U540 | |
| ILWGHRFEPVLFEEK | 321 | B7U540 | |
| LEEFDFHVRWPGVKL | 131 | O60763 | |
| NPDEEWREVRHTGLV | 731 | Q9BQF6 | |
| HTVDPSEWAEEELGF | 176 | Q96PX1 | |
| ENPIHIWDAFTGELR | 251 | Q9BUR4 | |
| SLVAAEWRPEEGFVE | 76 | Q7Z6J9 | |
| FSEEWEAQRDSHLGP | 336 | P49768 | |
| LSVDDVFQGADWERP | 576 | Q8N103 | |
| IFAGHDKWSLDPRVE | 71 | Q13449 | |
| RAEHSVDIDVDIDWP | 241 | Q8NFW8 | |
| IPEEDDFGDVLWDIH | 471 | Q7Z494 | |
| HPGVIRLLDWFETQE | 96 | Q9P1W9 | |
| LPCDVIWLDIEHADG | 421 | Q14697 | |
| FDEGPVRLSHWQSEG | 181 | Q9BRB3 | |
| DVFEDPALWSLLHFR | 41 | Q6P050 | |
| WSVSGVDADPDLVHV | 296 | Q96PQ0 | |
| CHPWLFIEEAAGREV | 586 | Q96HU1 | |
| SHSDDRWFDPLDPLE | 1281 | O60292 | |
| VPREEEDGLVAWFAL | 216 | Q9BQG2 | |
| DRGETHLWSPQVSED | 81 | Q53GG5 | |
| HRELHGDFVAPEQLW | 246 | Q9H5K3 | |
| EPREHAWILAAAEGR | 111 | A6NJG2 | |
| VEWHISRPGHIETFD | 761 | Q07889 | |
| QFAALDPEHRGHIEW | 251 | Q9UPV7 | |
| PGEESFEVWLDHTTE | 166 | P0CW24 | |
| VLWDHLSEKRVEPGF | 356 | Q86UX6 | |
| PVGHRFFVDGDWSVL | 766 | P36956 | |
| TLGEAVTDHPDRLWA | 6 | P56279 | |
| HPNLWEEVTDGDLDT | 221 | Q53RT3 | |
| DTPWLRDFHDPVVEV | 106 | Q9UGN4 | |
| AAHGFDWEEERQPIL | 156 | Q15021 | |
| LEHARPEEPSWDEDF | 111 | Q9NQ89 | |
| EVLDGSRVHPETYEW | 1051 | Q7KZ85 | |
| RFPLRDAVEEGDWTA | 76 | P21980 | |
| DNDVLLHWAPVEEAG | 41 | Q9HA65 | |
| DLHGSEEREWPESVS | 76 | Q9BSG1 | |
| EEDPIWDQETHLRGN | 16 | Q96LW9 | |
| WFLERGHTDITVFVP | 166 | Q5D1E8 | |
| AWLREHRPENGEEAV | 106 | Q86W11 | |
| PESGEEAVALVEDWH | 116 | P17040 | |
| FLHEDESSDALPEWP | 381 | Q9NXB0 | |
| HWLRTQFPSLDIEGD | 161 | Q2QD12 | |
| DIISDPDSHFPAWRE | 411 | Q8IXW5 | |
| LVWDHDPIGRDFIGQ | 836 | O75038 | |
| AVIRFESIIHEFDPW | 91 | Q8TCJ2 | |
| VEFSLEEWEHLEPAQ | 11 | Q14586 | |
| THLAPEAFWGLEALR | 266 | Q7L0X0 | |
| AEESGRLWSEEQPAH | 36 | Q96J42 | |
| RHFIEVPEGATWAEV | 661 | P29144 | |
| GSEIWRDIDFAHEAP | 191 | P14679 | |
| DVAVVFSPEEWDHLT | 46 | A6NDX5 | |
| EIHAVWEPLIERVEG | 2331 | Q709C8 | |
| VSWLLEIGEIHRPEE | 416 | Q70Z35 | |
| GLEPLAWSEDHRVSV | 66 | Q9UKN8 | |
| LWFPGESESFEDAHV | 141 | Q9NZC2 | |
| AEPSSGRWVHLDTEI | 676 | Q9BZ71 | |
| VWDHDPIGRDFVGQR | 811 | Q4KWH8 | |
| RGAEVTVVPWDHALD | 196 | P27708 | |
| DARGLFWVLDEEVHV | 1031 | Q8IUG5 | |
| VETVPEAGRHEELYW | 86 | Q14588 | |
| RTEIVHVWPGTDGFL | 536 | Q9HBF4 | |
| EFTREEWQHLGPVER | 16 | Q5TYW1 | |
| DVHWTRAGEVQEPEL | 236 | P25311 | |
| ELISWIEHGGEPFRK | 56 | Q8N393 | |
| IEHGGEPFRKWRESQ | 61 | Q8N393 | |
| GLAWEELAAPRDVFS | 191 | Q8N398 | |
| RGFPEDLWSIHDLEA | 76 | P17030 | |
| FIAPWFHGIISREDA | 321 | Q5SQS7 | |
| WGPAAFTEAELEERE | 561 | Q9UH65 | |
| EEDRVVVIRFGHDWD | 21 | P83876 | |
| REGWFSVTPEKIAEH | 666 | Q96RS0 | |
| GASWELQSLRPHDED | 176 | Q96N95 | |
| HASSFEEWGRRHPEE | 701 | Q9H4Z2 | |
| RGDHEVEQWALPSDT | 371 | P21754 | |
| VLWDLDIPEGRSHAD | 101 | Q6PEX7 | |
| VLWGHRFFPVISLEE | 321 | P48549 | |
| RDIQAPDGLAVDWIH | 471 | P01130 | |
| FWHVREEEFVCEPPL | 276 | Q9ULH4 | |
| HPWHRDTDLEFVDGE | 371 | Q8N145 | |
| ITHFGPEEAWRLALS | 61 | P59046 | |
| AVHALIDVWRETGDE | 471 | Q14CX7 | |
| VRWEEAAPGRAVEHA | 161 | Q6NSJ0 |